Ranjana Srivastava

Ranjana Srivastava is an experienced project manager with a strong background in biochemistry and a focus on vaccine development and data management. Currently serving as Project Manager at ABL Inc. since January 2018, Ranjana previously worked as Vaccine Project Manager at Glaxo Smith Kline Pharmaceuticals and as an Independent Consultant at Alphient. Earlier roles include Management Consultant at Booz Allen Hamilton, where Ranjana provided expertise for strategic program development in semantics for the National Institutes of Health, and Senior Research Scientist/Project Manager at Kevric/IMC, leading projects for the National Cancer Institute. Ranjana started a career at Celera Genomics as a Senior Research Scientist, integrating genomic data into databases. Educational qualifications include a PhD in Biochemistry from Central Drug Research Institute and an MS in Biochemistry from Lucknow University.